Sarcoidosis following successful treatment of pemphigus vulgaris with rituximab: a rituximab-induced reaction further supporting B-cell contribution to sarcoidosis pathogenesis?

Cytotoxic agents in sarcoidosis

(2014) Adriane D.M. Vorselaars et al.   CURRENT OPINION IN PULMONARY MEDICINE

Elevated serum BAFF levels in patients with sarcoidosis: association with disease activity

(2013) Ikuko Ueda-Hayakawa et al.   RHEUMATOLOGY

Long-Term Remissions of Severe Pemphigus After Rituximab Therapy Are Associated with Prolonged Failure of Desmoglein B Cell Response

(2013) N. Colliou et al.   Science Translational Medicine

New onset sarcoid-like granulomatosis developing during anti-TNF therapy: an under-recognised complication

(2011) D. Tong et al.   INTERNAL MEDICINE JOURNAL

The Sarcoid-Lymphoma Syndrome

(2010) Trishna Goswami et al.   Clinical Lymphoma Myeloma & Leukemia

Rituximab Mediates a Strong Elevation of B-Cell-Activating Factor Associated with Increased Pathogen-Specific IgG but Not Autoantibodies in Pemphigus Vulgaris

(2009) Angela Nagel et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

B-Cell Depletion Immunotherapy in Pemphigus: Effects on Cellular and Humoral Immune Responses

(2008) Hugo Mouquet et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY